Analysts Offer Insights on Healthcare Companies: 3SBio (OtherTRSBF), UnitedHealth (UNH) and Caribou Biosciences (CRBU)
Nomura Adjusts Angelalign Technology's Price Target to HK$62.84 From HK$61.39, Keeps at Neutral.
Nomura Adjusts Angelalign Technology's Price Target to HK$61.39 From HK$126.29, Keeps at Neutral
Nomura Adjusts Angelalign Technology’s Price Target to HK$126.29 From HK$128.51, Keeps at Neutral
Nomura Adjusts Angelalign Technology’s Price Target to HK$128.51 From HK$146.97, Keeps at Neutral
Nomura Adjusts Angelalign Technology's Price Target to HK$146.97 From HK$169.50, Keeps at Neutral
Correction: --UBS Adjusts Arrail Group's Price Target to HK$15.8 From HK$16, Keeps at Buy
Nomura Adjusts Arrail Group's Price Target to HK$15.8 From HK$16, Keeps at Buy